More on ABVX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.2 Score)

Upcoming Events

- Earnings (12/14/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Abivax (NQ:ABVX)
Delayed: 88.40 -3.98 (4.31%)
Prev. Close $92.38  
Open$91.48 
52 Wk High$ 
52 Wk Low$ 
Day High$91.48 
Day Low$87.05 
P/E N/A  
EPS$ 
Volume659,925 

Friends, Peers and Foes (?): AAVXF, LLY, COGT, ADVM, INSM (more...)

Sep 30, 2026 04:05 PM Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep 22, 2026 07:15 AM Abivax (ABVX) PT Lowered to $151 at Truist Securities
Sep 21, 2026 04:21 PM Form F-6EF Abivax S.A. Filed by: Citibank,N.A./ADR
Sep 21, 2026 04:13 PM Form 6-K Abivax S.A. For: Jun 30
Sep 21, 2026 04:05 PM Abivax Presents Business Updates and First Half 2026 Financial Results 
Sep 10, 2026 05:00 PM This biotech stock has 'multiblockbuster IBD opportunity': analyst
Sep 9, 2026 04:41 PM Goldman Sachs Starts Abivax (ABVX) at Buy, 'screens well as a potential M&A target'
Aug 14, 2026 04:31 PM Form SCHEDULE 13G/A Abivax S.A. Filed by: TCG Crossover GP I, LLC
Aug 13, 2026 10:55 AM Form SCHEDULE 13G/A Abivax S.A. Filed by: Invus Global Management, LLC
Jul 30, 2026 04:07 PM Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
View All Articles

Entities mentioned with ABVX

View All Entities